Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017

C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review

MS Salahudeen, SB Duffull, PS Nishtala - BMC geriatrics, 2015 - Springer
Background The cumulative effect of taking multiple medicines with anticholinergic
properties termed as anticholinergic burden can adversely impact cognition, physical …

NCCN guidelines® insights: older adult oncology, version 1.2021: featured updates to the NCCN guidelines

E Dotan, LC Walter, IS Browner, K Clifton… - Journal of the National …, 2021 - jnccn.org
The NCCN Guidelines for Older Adult Oncology address specific issues related to the
management of cancer in older adults, including screening and comprehensive geriatric …

Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review

C Fox, T Smith, I Maidment, WY Chan, N Bua… - Age and …, 2014 - academic.oup.com
Objectives: to determine the effect of drugs with anti-cholinergic properties on relevant
health outcomes. Design: electronic published and unpublished literature/trial registries …

Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence

A Collamati, AM Martone, A Poscia, V Brandi… - Aging clinical and …, 2016 - Springer
The use of medication with anticholinergic properties is widespread among older subjects.
Many drugs of common use such as antispasmodics, bronchodilators, antiarrhythmics …

Anticholinergic drugs in geriatric psychopharmacology

J López-Álvarez, J Sevilla-Llewellyn-Jones… - Frontiers in …, 2019 - frontiersin.org
Drugs with anticholinergic action are widely prescribed in the elderly population due to their
potential clinical benefits. However, these benefits are limited by adverse effects which may …

Anticholinergics: theoretical and clinical overview

PS Nishtala, MS Salahudeen… - Expert opinion on drug …, 2016 - Taylor & Francis
Introduction: Anticholinergics are a class of medicines that block the neurotransmitter,
acetylcholine, in the brain and peripheral tissues. Medicines with anticholinergic activity are …

Anticholinergic drug burden tools/scales and adverse outcomes in different clinical settings: a systematic review of reviews

TJ Welsh, V van der Wardt, G Ojo, AL Gordon… - Drugs & aging, 2018 - Springer
Background Cumulative anticholinergic exposure (anticholinergic burden) has been linked
to a number of adverse outcomes. To conduct research in this area, an agreed approach to …

Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people

MS Salahudeen, SN Hilmer… - Journal of the American …, 2015 - Wiley Online Library
Objectives To investigate whether anticholinergic burden scores from nine published
anticholinergic scales are associated with adverse health outcomes, including hospital …

Multimorbidity and polypharmacy in the elderly: lessons from REPOSI

PM Mannucci, A Nobili… - Internal and emergency …, 2014 - Springer
The dramatic demographic changes that are occurring in the third millennium are modifying
the mission of generalist professionals such as primary care physicians and internists …